Articles

The shortage is a lucrative opportunity — but the window is brief.

There’s a proxy vote to change the fund, and the calls will keep coming until the matter is settled.

ETF investors stuck with tech through a turbulent November.

Share prices for both suitors are down over 5% as details emerge of cash bids for the owner of HBO and CNN.

Bristol Myers’ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer’s treatment, even though the outcome of a late-stage trial has been delayed.

“I am curious as to why Delta didn’t ask me, the account holder, whether this was OK.”

Adjusting sales quotas early in the fiscal year is not surprising, says one analyst who sees weakness in the stock as a buying opportunity.

With pandemic-era subsidies for Obamacare marketplace plans set to end in 2026, people in the FIRE community are adjusting their plans to account for bigger health-insurance premiums.

The Centers for Medicare and Medicaid Services just proposed vacating a rule that would have alerted beneficiaries about their unused benefits.

Investors need to be careful if they place early bets on startup companies seeking to provide nuclear-generated electricity for data centers, according to Paul Wick of Columbia Threadneedle Investments.

Demand in the December quarter “remains healthy,” and the price tag was not as high as Wall Street feared.

U.S. Treasury Secretary Scott Bessent on Wednesday expressed confidence that the Supreme Court will rule in favor of the Trump administration’s many country-specific tariffs, while also saying administration officials are ready to maintain the levies through other avenues.